Popular Articles

Study Examines 'Elite' Group Of HIV-Positive People Who Appear 'Protected' From Developing AIDS
An international contingent of nearly 500 researchers and physicians are taking part in the International HIV Controllers Study, which is examining "the phenomenon," in which certain people living with HIV seem "somehow protected from AIDS," the Washington Post reports. Fewer "than one in every 300 cases, or perhaps 5,000 of the more than 1 million infected Americans" living with HIV are deemed ""elite controllers" because their ability to combat the virus puts them in exceptional company among infected individuals," according to the Post. The article states, "No one knows how their bodies keep AIDS at bay. Are their immune systems exceptionally strong and effective? Do they possess some genetic trait that protects them? Or does a combination of still-unknown factors set them apart?" Researchers anticipate that studying the T cell levels - which helps determine the progression to AIDS - of the elite controllers, will enable them "to uncover what shields these rare few from AIDS. And perhaps in the process they"ll find a way to safeguard everyone else as well," the Post reports (Slack, 7/7). Buy arimidex to treat cancer.

Prospective Clinical Advantages Of Trabecular Metal(TM) Technology Highlighted In Comparative Study
Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH) announced that data from a comparative clinical study conducted by researchers at the Mayo Clinic and the Joint Replacement Surgeons of the Indiana Research Foundation describes the low stiffness and osteoconductive properties of Zimmer"s Trabecular Metal Technology. The study, published in The Journal of Arthroplasty, found significant reductions in acetabular bone loss adjacent to the Trabecular Metal device compared to the titanium component, and a significant relative increase in bone mineral density (BMD) after total hip arthroplasty (THA) using implants made with Zimmer"s proprietary Trabecular Metal Technology.

generic viagra online


News of the day
AARP Biologics Study Based On Fuzzy Math, Flawed Assumptions
The following statement was issued by the Biotechnology Industry Organization (BIO) regarding a study on biosimilars presented to Congressional staff by the AARP:
Public Health

Greater Incidence Of Inflammatory Bowel Disease In Specific Populations

receiving Medicare or Medicaid, a factor which Dr. Nguyen said should be looked at more closely. Dr. Nguyen presented these data on May 31. The Changing Pattern of Crohn"s Disease Incidence According to Age in Northern France: A Constant Increase in the 0-19 Years Age Group (Abstract #114) A population-based study of residents in northern France finds that the incidence of Crohn"s disease (CD) is on the rise, most dramatically among young people less than 19 years of age. The findings raise a number of questions about the likely causes of the increase, which the investigators say could be related to environmental factors. Investigators from the EPIMAD registry in France tracked rates of CD among nearly six million patients in northern France between 1988 and 2005. They found that the incidence of CD among all patients increased 20.7 percent but that rates had stabilized 10 years into the study. Among young people less than 19 years of age however, the incidence of CD increased linearly by 48.5 percent. The cause of the increased incidence of CD among young people is unknown, but investigators say aggravating factors like environmental pollution and changes in diet or smoking habits could be culprits. "Since we now know that CD disproportionately affects young people, future studies to uncover its cause should focus on this age group," said Guillaume Savoye, MD, EPIMAD registry and department of gastroenterology, University Hospital, Rouen, France. Dr. Savoye presented these data on May 31. Aimee Frank American Gastroenterological Association

Pages: 1 [2] 


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):